309 related articles for article (PubMed ID: 1730918)
1. Requirements for hyaluronic acid binding by CD44: a role for the cytoplasmic domain and activation by antibody.
Lesley J; He Q; Miyake K; Hamann A; Hyman R; Kincade PW
J Exp Med; 1992 Jan; 175(1):257-66. PubMed ID: 1730918
[TBL] [Abstract][Full Text] [Related]
2. CD44 can be activated to function as an hyaluronic acid receptor in normal murine T cells.
Lesley J; Hyman R
Eur J Immunol; 1992 Oct; 22(10):2719-23. PubMed ID: 1382996
[TBL] [Abstract][Full Text] [Related]
3. Antibody-induced activation of the hyaluronan receptor function of CD44 requires multivalent binding by antibody.
Lesley J; Kincade PW; Hyman R
Eur J Immunol; 1993 Aug; 23(8):1902-9. PubMed ID: 7688309
[TBL] [Abstract][Full Text] [Related]
4. Ankyrin-binding domain of CD44(GP85) is required for the expression of hyaluronic acid-mediated adhesion function.
Lokeshwar VB; Fregien N; Bourguignon LY
J Cell Biol; 1994 Aug; 126(4):1099-109. PubMed ID: 7519619
[TBL] [Abstract][Full Text] [Related]
5. Regulation of human CD44H and CD44E isoform binding to hyaluronan by phorbol myristate acetate and anti-CD44 monoclonal and polyclonal antibodies.
Liao HX; Levesque MC; Patton K; Bergamo B; Jones D; Moody MA; Telen MJ; Haynes BF
J Immunol; 1993 Dec; 151(11):6490-9. PubMed ID: 7504022
[TBL] [Abstract][Full Text] [Related]
6. Role of CD44 cytoplasmic domain in hyaluronan binding.
Perschl A; Lesley J; English N; Trowbridge I; Hyman R
Eur J Immunol; 1995 Feb; 25(2):495-501. PubMed ID: 7533087
[TBL] [Abstract][Full Text] [Related]
7. Molecular isoforms of murine CD44 and evidence that the membrane proximal domain is not critical for hyaluronate recognition.
He Q; Lesley J; Hyman R; Ishihara K; Kincade PW
J Cell Biol; 1992 Dec; 119(6):1711-9. PubMed ID: 1469058
[TBL] [Abstract][Full Text] [Related]
8. A cysteine residue located in the transmembrane domain of CD44 is important in binding of CD44 to hyaluronic acid.
Liu D; Sy MS
J Exp Med; 1996 May; 183(5):1987-94. PubMed ID: 8642309
[TBL] [Abstract][Full Text] [Related]
9. Hyaluronan binding function of CD44 is transiently activated on T cells during an in vivo immune response.
Lesley J; Howes N; Perschl A; Hyman R
J Exp Med; 1994 Jul; 180(1):383-7. PubMed ID: 7516415
[TBL] [Abstract][Full Text] [Related]
10. Site-specific de-N-glycosylation of CD44 can activate hyaluronan binding, and CD44 activation states show distinct threshold densities for hyaluronan binding.
English NM; Lesley JF; Hyman R
Cancer Res; 1998 Aug; 58(16):3736-42. PubMed ID: 9721887
[TBL] [Abstract][Full Text] [Related]
11. The role of the CD44 cytoplasmic and transmembrane domains in constitutive and inducible hyaluronan binding.
Lesley J; English N; Charles C; Hyman R
Eur J Immunol; 2000 Jan; 30(1):245-53. PubMed ID: 10602047
[TBL] [Abstract][Full Text] [Related]
12. CD44 expression on activated B cells. Differential capacity for CD44-dependent binding to hyaluronic acid.
Hathcock KS; Hirano H; Murakami S; Hodes RJ
J Immunol; 1993 Dec; 151(12):6712-22. PubMed ID: 7505013
[TBL] [Abstract][Full Text] [Related]
13. Binding of cell-surface expressed CD44 to hyaluronate is dependent on splicing and cell type.
van der Voort R; Manten-Horst E; Smit L; Ostermann E; van den Berg F; Pals ST
Biochem Biophys Res Commun; 1995 Sep; 214(1):137-44. PubMed ID: 7545390
[TBL] [Abstract][Full Text] [Related]
14. Role of the extracellular and cytoplasmic domains of CD44 in the rolling interaction of lymphoid cells with hyaluronan under physiologic flow.
Gal I; Lesley J; Ko W; Gonda A; Stoop R; Hyman R; Mikecz K
J Biol Chem; 2003 Mar; 278(13):11150-8. PubMed ID: 12540844
[TBL] [Abstract][Full Text] [Related]
15. Hyaluronic acid-induced lymphocyte signal transduction and HA receptor (GP85/CD44)-cytoskeleton interaction.
Bourguignon LY; Lokeshwar VB; Chen X; Kerrick WG
J Immunol; 1993 Dec; 151(12):6634-44. PubMed ID: 7505012
[TBL] [Abstract][Full Text] [Related]
16. CD44-dependent lymphoma cell dissemination: a cell surface CD44 variant, rather than standard CD44, supports in vitro lymphoma cell rolling on hyaluronic acid substrate and its in vivo accumulation in the peripheral lymph nodes.
Wallach-Dayan SB; Grabovsky V; Moll J; Sleeman J; Herrlich P; Alon R; Naor D
J Cell Sci; 2001 Oct; 114(Pt 19):3463-77. PubMed ID: 11682606
[TBL] [Abstract][Full Text] [Related]
17. Hyaluronate is costimulatory for human T cell effector functions and binds to CD44 on activated T cells.
Galandrini R; Galluzzo E; Albi N; Grossi CE; Velardi A
J Immunol; 1994 Jul; 153(1):21-31. PubMed ID: 7515923
[TBL] [Abstract][Full Text] [Related]
18. Binding of CD44 to hyaluronic acid can be induced by multiple signals and requires the CD44 cytoplasmic domain.
Liu D; Zhang D; Mori H; Sy MS
Cell Immunol; 1996 Nov; 174(1):73-83. PubMed ID: 8929456
[TBL] [Abstract][Full Text] [Related]
19. Defective phosphorylation and hyaluronate binding of CD44 with point mutations in the cytoplasmic domain.
Puré E; Camp RL; Peritt D; Panettieri RA; Lazaar AL; Nayak S
J Exp Med; 1995 Jan; 181(1):55-62. PubMed ID: 7528778
[TBL] [Abstract][Full Text] [Related]
20. N-terminal and central regions of the human CD44 extracellular domain participate in cell surface hyaluronan binding.
Liao HX; Lee DM; Levesque MC; Haynes BF
J Immunol; 1995 Oct; 155(8):3938-45. PubMed ID: 7561101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
